Estimation of tolerance of a domestic non-steroid anti-inflammatory drug in the postoperative period of extraction of cataracts
Autor: | F. Bakhritdinova, K.I. Narzikulova Kumri Islamovna, Sh.A. Yusupov, M.E. Egamberdieva |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Вісник медичних і біологічних досліджень, Vol 3, Iss 2, Pp 103-106 (2021) |
Druh dokumentu: | article |
ISSN: | 2706-6290 2706-6282 |
DOI: | 10.11603/bmbr.2706-6290.2021.2.12343 |
Popis: | The article discusses the efficacy and tolerability of a non-steroidal anti-inflammatory domestic drug after cataract extraction, the severity of side effects of a non-steroidal anti-inflammatory drug. The aim of the study – optimization of methods of postoperative treatment of cataracts using the domestic non-steroidal anti-inflammatory Diclofenac drug, 0.1 % eye drops, produced by JV “Jurabek Laboratories” LLC. Materials and Methods. The study included patients who were at inpatient treatment at the Clinic No. 2 of the Tashkent Medical Academy. The study group included 60 people: 21 men and 39 women, the age of patients was 18–73 years. In two groups, we compared the efficacy and tolerability of domestic and foreign NSAIDs after cataract extraction. Results. The effectiveness of the complex treatment is confirmed by the reduction in the duration of relief of the main symptoms of inflammation in patients of both groups. Both drugs did not cause side effects and were well tolerated by patients. Tolerability of the treatment in the group receiving domestic NSAIDs was 93.4 %, in the group receiving foreign NSAIDs – 95.7 %. Conclusions. According to the results of our studies, it was proved that therapy after cataract extraction with the use of a domestic-made NSAID is not inferior in efficiency and tolerability to a foreign-made drug and can be used in the postoperative period of cataract |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |